Leveraging analytics to assure quality during the Covid-19 pandemic - The COVACTA clinical study example

Leveraging analytics to assure quality during the Covid-19 pandemic - The COVACTA clinical study example

The world has seen a shift in the ways of working during the Covid-19 pandemic. Routine activities performed at the clinical investigator sites (e.g. on-site audits) that are a part of Quality Assurance (QA) have not been feasible at this time. Analytics has played a huge role in contributing to our...

Full description

Bibliographic Details
Main Authors: Timothé Ménard, Rich Bowling, Pooja Mehta, Björn Koneswarakantha, Eileen Magruder
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Contemporary Clinical Trials Communications
Subjects:
Quality Assurance
Clinical Trials
Analytics
Audit
Clinical Data Monitoring
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420301460
Description
Summary:The world has seen a shift in the ways of working during the Covid-19 pandemic. Routine activities performed at the clinical investigator sites (e.g. on-site audits) that are a part of Quality Assurance (QA) have not been feasible at this time. Analytics has played a huge role in contributing to our continued efforts of ensuring quality during the conduct of a clinical trial. Decisions driven through data, now more than ever, heavily contribute to the efficiency of QA activities. In this report, we share the approach we took to conduct QA activities for the COVACTA study (to treat Covid-19 pneumonia) by leveraging analytics.
ISSN:2451-8654

Similar Items